英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
VU 0364439
|
1246086-78-1 |
VU 364439
|
VU 0364439;VU0364439;VU-0364439;VU 0364439 10MG;CS-629;N-[3-氯-4-[[(2-氯苯基)氨基]磺酰基]苯基]-2-吡啶甲酰胺
|
C18H13Cl2N3O3S |
422.28512 | |
IWR-1-endo
|
1127442-82-3 |
IWR-1
|
ENDO-IWR 1;IWR-1-ENDO;IWR1;IWR 1;InSolution鈩Wnt Antagonist I,IWR-1-endo-CAS 1127442-82-3-Calbiochem;REL-4-[(3AR,4S,7R,7AS)-1,3,3A,4,7,7A-六氢-1,3-二氧代-4,7-甲桥-2H-异吲哚-2-基]-N-8-喹啉基苯甲酰胺
|
C25H19N3O3 |
409 | |
ZM 323881 hydrochloride
|
324077-30-7 |
ZM 323881 HCL
|
ZM323881/ZM-323881;ZM 323881 HYDROCHLORIDE
5-((7-BENZYLOXYQUINAZOLIN-4-YL)AMINO)-4-FLUORO-2-METHYLPHENOL HYDROCHLORIDE;ZM 323881 HYDROCHLORIDE;5-((7-BENZYLOXYQUINAZOLIN-4-YL)AMINO)-4-FLUORO-2-METHYLPHENOL HYDROCHLORIDE
|
C22H19ClFN3O2 |
411.8565632 | |
CID 2011756
|
638156-11-3 |
CID-211756
|
CID-2011756,5-(3-chlorophenyl)-N-(4-(MorpholinoMethyl)phenyl)furan-2-carboxaMide;CID 2011756;CID-2011756, >97%;5-(3-chlorophenyl)-N-(4-(MorpholinoMethyl)phenyl)furan-2-carboxaMide;5-(3-Chlorophenyl)-N-[4-morpholin-4-ymethyl)phenyl]furan-2-carboxamide;5-(3-Chlorophenyl)-N-[4-(4-morpholinylmethyl)phenyl]-2-furancarboxamide;5-(3-Chlorophenyl)-N-[4-(morpholin-4-ylmethyl)phenyl]furan-2-carboxamide;CID-2011756, >=98%
|
C22H21ClN2O3 |
396.86674 | |
BI-D1870
|
501437-28-1 |
BI-D187
|
BID1870;BI-D 1870;2-[(3,5-二氟-4-羟基苯基)氨基]-7,8-二氢-5,7-二甲基-8-(3-甲基丁基)-6(5H)-蝶啶酮
|
C19H23F2N5O2 |
391.42 | |
INCB018424(Ruxolitinib)
|
1160597-27-2 |
鲁索利替尼
|
|
C17H18N6 |
306.37 | |
JNJ7777120
|
459168-41-3 |
JNJ777712
|
(5-氯-1H-吲哚-2-基((4-甲基哌嗪-1-基(甲酮;1-[(5-氯-1H-吲哚-2-基(羰基]-4-甲基哌嗪;CS-593;JNJ-7777120;JNJ7777120
|
C14H16ClN3O |
277.753 | |
AST-1306
|
897383-62-9 |
AST-136
|
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]氨基]-6-喹唑啉基]-2-丙烯酰胺;CS-590
|
C24H18ClFN4O2 |
448.876723 | |
tenofovir disoproxil
|
201341-05-1 |
替诺福韦酯
|
替诺福韦双索酯;(R)-9-(2-磷酸甲氧基丙基)腺嘌呤二(异丙氧羰基氧甲基)酯;替诺福韦酯;替诺福韦二吡呋酯;CS-590;TENOFOVIR DISOPROXIL (BIS(POC)-PMPA);替诺福韦酯(富马酸盐)
|
C19H30N5O10P |
519.44 | 606-442-6 |
NETOBIMIN
|
88255-01-0 |
奈韦拉平
|
奈托比胺;奈韦拉平;尼妥必敏;CS-588;奈托比胺
|
C14H20N4O7S2 |
420.46 | 686-284-2 |
Tirofiban
|
144494-65-5 |
替罗非班
|
替罗非班;(2S)-2-(丁基磺酰氨基)-3-[4-[4-(4-哌啶基)丁氧基]苯基]丙酸;AGGRASTAT;L700462;MK383;N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸;替洛非巴;替罗非班-D6;盐酸替罗非班-D9;CS-585
|
C22H36N2O5S |
440.59664 | 635-682-4 |
Rocilinostat
|
1316214-52-4 |
ACY1215
|
ACY 1215;RICOLINOSTAT;2-(二苯基氨基)-N-[7-(羟基氨基)-7-氧代庚基]-5-嘧啶羧酰胺;CS-583;RICOLINOSTAT;ACY1215;ACY 1215;2-(二苯基氨基)-N-[7-(羟基氨基)-7-氧代庚基]-5-嘧啶甲酰胺
|
C24H27N5O3 |
433.50288 | |
CP 945598 hydrochloride
|
686347-12-6 |
CP945598
|
CP-945598;CP 945598;OTENABANT;CP945598;CP 945598;CS-580;奥特那班盐酸盐
|
C25H26Cl3N7O |
546.87924 | |
Apoptosis Activator 2
|
79183-19-0 |
APOPTOSIS ACTIVATOR 2
|
MDK83190;1-(3,4-二氯苄基)-1H-吲哚-2,3-二酮;凋亡活化剂 2;CS-572;凋亡激活剂 2;细胞凋亡激活剂2,一种细胞色素C半胱天冬酶活化剂和凋亡诱导物
|
C15H9Cl2NO2 |
306.14 | 200-256-5 |
Tenovin-1
|
380315-80-0 |
TENOVIN-1
|
Tenovin-1;CS-571;N-[[[4-(乙酰氨基)苯基]氨基]硫代甲酰]-4-叔丁基苯甲酰胺;N-[[[4-(乙酰氨基)苯基]氨基]硫代甲酰]-4-叔丁基苯甲酰胺(TENOVIN-1);TENOVIN-1;TENOVIN 1;N-((4-乙酰氨基苯基)硫代氨基甲酰基)-4-(叔丁基)苯甲酰胺
|
C20H23N3O2S |
369.487 | 200-256-5 |
Dapivirine
|
244767-67-7 |
DAPIVIRINE
|
4-[[4-[(2,4,6-三甲基苯基)氨基]-3-嘧啶基]氨基]-苯腈
|
C20H19N5 |
329.405 | |
UNC0638
|
1255580-76-7 |
UNC638
|
CS-565;2-环己基-6-甲氧基-N-[1-异丙基-4-哌啶基]-7-[3-(1-吡咯烷基(丙氧基]-4-喹唑啉胺
|
C30H47N5O2 |
509.72648 | |
IOX 2
|
931398-72-0 |
IOX 2
|
N-[[4-羟基-2-氧代-1-(苯基甲基)-1,2-二氢-3-喹啉基]羰基]甘氨酸(IOX-2);2-(1-苄基-4-羟基-2-氧代-1,2-二氢喹啉-3-甲酰氨基)乙酸
|
C19H17N2O4 |
337.34928 | 804-733-4 |
Bepotastine
|
190786-43-7 |
贝他斯汀
|
CS-560;(+)-(S)-4-[4-[(4-氯苯基)吡啶-2-基甲氧基]哌啶-1-基]丁酸;贝他斯汀;甜菜碱杂质
|
C21H25ClN2O3 |
388.89 | 1533716-785-6 |
zibotentan
|
186497-07-4 |
Zibotentan (ZD454)
|
N-(3-甲氧基-5-甲基-2-吡嗪基)-2-[4-(1,3,4-恶二唑-2-基)苯基]-3-吡啶磺酰胺;齐泊腾坦;2-(4-(1,4-噁二唑-2-基)苯基)-N-(3-甲氧基-5-甲基吡嗪-2-基)吡啶-3-磺酰胺;ZIBOTENTAN (ZD4054);ZD4054;ZD-4054;ZD 4054;ZIBOTENTAN (ZD4054)250MG;ZD4054;ZD-4054;ZD 4055
|
C19H16N6O4S |
424.43314 |